Abstract
AbstractC-STREAM, is a repurposed methodology which uses causal transport theory to standardize historical trials to a single target demographic. Validation shows that on complex simulated datasets a 60-80% reduction in unexplained heterogeneity is possible , revealing consistent efficacy.
Paper SummaryIntroduction Evidence synthesis issues stem from standard meta-analysis and its inability to distinguish between true biological failure and demographic effects . This problem often leads to "conflicting evidence" thatmay be an artifact of population variance.
Methodology C-STREAM solves this by shifting the unit of analysis from raw effect sizes to useful and well thought through counterfactual models. The engine employs three core innovations:
- Counterfactual Transport: g-computation to mathematically re-weight historical clinical trials, predicting treatment and their performance in a specific target patient population.
- Variance Decomposition: "Structural Heterogeneity" (true mechanical differences) is split from from "Transport Heterogeneity" (population mismatch).
- Transport-Aware VOI: This is validated but repurposed and generates Net Benefit curves to calculate the exact optimal sample size for future trials based on residual uncertainty.
Results Tested on simulations featuring high confounding and structural outliers, C-STREAM successfully resolved population mismatches. The approach achieved a 60-80% reduction in unexplained heterogeneity but needs further modeling.
Conclusion C-STREAM offers a new method toward more precision meta-analysis. By isolating biological efficacy (as opposed) to demographic noise.
References
1. Pearl, J., & Bareinboim, E. (2014). "External validity: From do-calculus to transportability across populations." Statistical Science, 29(4), 579-595.
2. Colditz, G. A., Brewer, T. F., Berkey, C. S., et al. (1994). "Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature." JAMA, 271(9), 698-702.
3. Dahabreh, I. J., et al. (2019). "Generalizing causal inferences from individuals in randomized trials to all trial-eligible individuals in clinical practice." Biometrics, 75(2), 685-694.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 ma6y ma6y; Andrew Woo
